Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2023 | Genocea Biosciences, Inc. Went Out of Business | CI |
2023 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
Sales 2020 | 1.36M 109M | Sales 2021 | 1.64M 131M | Capitalization | 66.64M 5.33B |
---|---|---|---|---|---|
Net income 2020 | -43M -3.44B | Net income 2021 | -33M -2.64B | EV / Sales 2020 | 50.8 x |
Net cash position 2020 | 55.9M 4.47B | Net cash position 2021 | 19.96M 1.6B | EV / Sales 2021 | 28.4 x |
P/E ratio 2020 |
-2.18
x | P/E ratio 2021 |
-2.4
x | Employees | 74 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 52 | 28/02/07 | |
Girish Aakalu
PRN | Corporate Officer/Principal | - | 09/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 10/09/14 |
Date | Price | Change | Volume |
---|---|---|---|
25/04/24 | - | -100.00% | 72 |
23/04/24 | 0.000001 | +∞% | 3,000 |
Delayed Quote OTC Markets, April 23, 2024 at 03:09 pm
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 58 | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GNCAQ Stock